Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-OPN-17012991Phase 4Recruiting
Phase 4, open-label trial of avatrombopag in adenomyosis (3 arms), sponsored by Tongji Hospital. Primary endpoints: Pain score and Menstrual bleeding score. Started May 2018; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-OPN-17012991.